Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond.
Saved in:
| Title: | Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond. |
|---|---|
| Authors: | Molica M; Division of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy., Simio C; Division of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy., De Fazio L; Division of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy., Alati C; Hematology and Stem Cell Transplantation and Cellular Rerapies Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Presidio Morelli, 89128 Reggio Calabria, Italy., Martino M; Hematology and Stem Cell Transplantation and Cellular Rerapies Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Presidio Morelli, 89128 Reggio Calabria, Italy., Rossi M; Division of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy. |
| Source: | Cancers [Cancers (Basel)] 2025 Nov 21; Vol. 17 (23). Date of Electronic Publication: 2025 Nov 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
